Reply: To PMID 25068637
- PMID: 25681024
- DOI: 10.1016/j.ajo.2014.12.016
Reply: To PMID 25068637
Comment on
-
Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study.Am J Ophthalmol. 2014 Nov;158(5):1032-8. doi: 10.1016/j.ajo.2014.07.027. Epub 2014 Jul 25. Am J Ophthalmol. 2014. PMID: 25068637 Clinical Trial.
-
Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study.Am J Ophthalmol. 2015 Mar;159(3):607-8. doi: 10.1016/j.ajo.2014.12.011. Am J Ophthalmol. 2015. PMID: 25681022 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources